Merck & Co.
As one of the seven largest pharmaceutical companies in the world by revenue and market capitalization, Merck & Co., Inc., continues to be a leader in the research and development of pharmaceutical products in its quest to improve both human and animal health. In line with its goal, Merck publishes a best-selling medical reference book known as the Merck Manual of Diagnosis and Therapy, more often referred to as The Merck Manual, which has become an indispensable resource for anyone studying medicine. First published in 1899, The Merck Manual has been periodically updated, with the latest version being available in online multimedia formats which include audio, animation and 3D models. Other Merck publications include the Merck Index for pharmacists, the Merck Veterinary Manual, and the Merck Manual of Geriatrics.
Merck's roots go back to a drug store in Darmstadt, Germany, owned by Friedrich Jacob Merck in 1668, and it was in 1891 that George Merck set up Merck & Co in the United States. Over the years, the company has developed and gone through a series of changes, all the while trying to remain true to its health-improving goal, despite a number of controversies (such as the much-publicized Vioxx recall) that may suggest otherwise. However, when a company is pioneering R&D in healthcare, addressing ever-evolving evolving diseases, a margin for error exists, and Merck’s prompt and decisive response to problems has been a reflection of the high standards it upholds.
Listed on the New York Stock Exchange (MRK), Merck states on its website that ethics and transparency are cornerstones of their corporate reputation. Moreover, Merck remains dedicated to devoting time and resources in meeting the most critical health needs of consumers. Merck has earned a number of awards as an employer that ranks the needs of its employees high on its priority scale, ensuring job satisfaction, productivity and loyalty – qualities not often found in the modern workplace.
- Video: Gertler Discusses Federal Open Market Committee Meeting: Video
- Monday 15 March 2010, 1:28 pm - Video: Gardner Says Fed Likely to Oversee Consumer Protection: Video
- Monday 15 March 2010, 1:25 pm - Video: Conan O'Brien Uses Twitter Popularity to Promote Tour: Video
- Monday 15 March 2010, 1:12 pm - Video: Wallison Doubts Dodd's Bill Would Prevent Another Crisis: Video
- Monday 15 March 2010, 1:02 pm - Video: U.S. Says Prius Investigation May Not Yield Answers: Video
- Monday 15 March 2010, 12:48 pm - Video: Nike, Paris Soccer Club Face Trial Over Player Payments
- Monday 15 March 2010, 12:45 pm
- Influential Institutional Investors
- Thursday 11 March 2010 - Features - Legislation Proposed to Regulate Financial Advisors
- Monday 8 March 2010 - Markets - Sarbanes-Oxley Act – Protecting Investor Interests
- Thursday 4 March 2010 - News - Fairtrade – Promoting Sustainable Development
- Monday 1 March 2010 - News - Three Pillars of the Basel II Accord
- Thursday 25 February 2010 - News - Final Week of February May Prove Challenging on Wall Street
- Monday 22 February 2010 - News
everton rhoden: who is incharge of stock in friench guyane...
www.stockmarkets.com/blog/january-ends-on-low-note-dragged-down-by-techs


User Comments & Reviews
Leave a comment: